营养不良和相关营养不足对老年人死亡率的影响
Elifnur Aydın1, Müberra Tanrıverdi2, Ozge Pasin3
1Bezmialem Vakıf University, Faculty of Medicine, Turkey.
Clinical nutrition ESPEN
|September 26, 2025
概括
营养不良和营养不足显著增加了老年人的死亡风险. 解决营养状况,包括减肥和食欲,对于改善老年护理结果至关重要.
科学领域:
- 老年医学 老年医学
- 营养科学 营养科学
- 公共卫生 公共卫生
背景情况:
- 营养状况是老年人健康结果的关键决定因素.
- 各种营养指标可能会影响死亡率,但它们的独立影响需要澄清.
研究的目的:
- 调查老年门诊患者多种营养指标与死亡率之间的关联.
- 确定预测老年人群死亡率的关键营养因素.
主要方法:
- 对1911名老年门诊患者的回顾性队列研究 (平均年龄为81.0岁,女性为70.8%).
- 评估营养状况 (MNA),消化不良 (EAT-10),食欲丧失 (CNAQ) 和维生素缺乏 (B12,叶酸,D).
- 分析了平均随访71.61个月的死亡率数据,并对年龄,性别和多病症进行了调整.
主要成果:
- 营养不良 (HR: 4.40),营养不良 (HR: 2.86),体重减轻≥3公斤 (HR: 2.45),营养不良风险 (HR: 2.13),消化不良 (HR: 1.71),食欲丧失 (HR: 1.62) 和维生素D缺乏 (HR: 1.62) 与增加的死亡率有关.
- 在完全调整后,只有营养不良仍然具有统计学意义 (HR:2.10).
结论:
- 营养不良,营养不足,显著的体重减轻,消化不良,食欲丧失和维生素D缺乏是老年人死亡风险的关键指标.
- 这些因素值得在临床上考虑,以便在老年患者中进行主动治疗.
- 在这个队列中,维生素B12和叶酸缺乏与死亡率没有显著的关联.
相关概念视频
Bone Disorders
5.1K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
5.1K
The Effect of Aging on Tissues
3.4K
Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
3.4K
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
237
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
237
Pharmacodynamics in Geriatric Patients: Effects of Age
188
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
188
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
232
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
232
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
197
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
197


